Sarah Cannon Research Institute
Temple Warden has extensive experience in clinical project administration and management, currently serving as Sr. Manager of Clinical Project Administration at Sarah Cannon since July 2017. With a career at Sarah Cannon Research Institute that began in October 2009 as a Sr. Clinical Project Associate, Temple has developed a strong foundation in clinical project support. Prior experience includes a role as Laboratory Processing Supervisor at LabCorp from October 2000 to July 2009, and earlier work as a Claims Resolution Clerk at Tennessee Managed Care/Access Med Plus from February 1994 to October 2000.
This person is not in the org chart
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.